MA20919A1 - Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine - Google Patents

Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine

Info

Publication number
MA20919A1
MA20919A1 MA21159A MA21159A MA20919A1 MA 20919 A1 MA20919 A1 MA 20919A1 MA 21159 A MA21159 A MA 21159A MA 21159 A MA21159 A MA 21159A MA 20919 A1 MA20919 A1 MA 20919A1
Authority
MA
Morocco
Prior art keywords
preparation
converting enzyme
enzyme inhibitors
angiotensin converting
nootropic activity
Prior art date
Application number
MA21159A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MA20919A1 publication Critical patent/MA20919A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Epoxy Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
MA21159A 1986-03-27 1987-03-25 Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine MA20919A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (de) 1986-03-27 1986-03-27 Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (1)

Publication Number Publication Date
MA20919A1 true MA20919A1 (fr) 1987-10-01

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
MA21159A MA20919A1 (fr) 1986-03-27 1987-03-25 Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine

Country Status (25)

Country Link
EP (1) EP0243645B1 (fr)
JP (1) JPS62240698A (fr)
KR (1) KR870008841A (fr)
CN (1) CN1031267C (fr)
AT (1) ATE102954T1 (fr)
AU (1) AU621278B2 (fr)
CA (1) CA1341064C (fr)
CS (2) CS276179B6 (fr)
DD (1) DD280765A5 (fr)
DE (2) DE3610391A1 (fr)
DK (1) DK172221B1 (fr)
EG (1) EG18175A (fr)
ES (1) ES2061447T3 (fr)
FI (1) FI91876C (fr)
HU (2) HU203117B (fr)
IE (1) IE62456B1 (fr)
MA (1) MA20919A1 (fr)
NO (1) NO178546C (fr)
NZ (1) NZ219764A (fr)
OA (1) OA08506A (fr)
PH (1) PH27210A (fr)
PT (1) PT84564B (fr)
RU (1) RU1836335C (fr)
TN (1) TNSN87045A1 (fr)
ZA (1) ZA872230B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) * 1987-09-16 1989-04-06 Hoechst Ag Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) * 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (fr) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Inhibiteurs de l'enzyme de conversion à activité psychotrope
DE3803225A1 (de) * 1988-02-04 1989-08-17 Hoechst Ag Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
JP2004532200A (ja) * 2001-03-15 2004-10-21 サエジス ファーマシューティカルズ， インコーポレイテッド 全身性ストレスの後に認識機能を回復するための方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050800B2 (fr) * 1980-10-23 1995-06-07 Schering Corporation Dipeptides carboxyalcoyliques, procédés pour les préparer et compositions pharmaceutiques les contenant
DE3300774A1 (de) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
OA08506A (fr) 1988-07-29
NO871282D0 (no) 1987-03-26
KR870008841A (ko) 1987-10-21
CN1031267C (zh) 1996-03-13
EP0243645B1 (fr) 1994-03-16
NO178546B (no) 1996-01-08
FI871304A (fi) 1987-09-28
PT84564A (de) 1987-04-01
FI91876B (fi) 1994-05-13
IE870784L (en) 1987-09-27
FI871304A0 (fi) 1987-03-25
EP0243645A3 (en) 1990-01-24
HU202118B (en) 1991-02-28
JPS62240698A (ja) 1987-10-21
AU621278B2 (en) 1992-03-12
TNSN87045A1 (fr) 1990-01-01
RU1836335C (ru) 1993-08-23
DE3610391A1 (de) 1987-10-08
CA1341064C (fr) 2000-08-01
CS212687A3 (en) 1992-04-15
ATE102954T1 (de) 1994-04-15
ES2061447T3 (es) 1994-12-16
NO871282L (no) 1987-09-28
PT84564B (pt) 1989-11-10
HUT46046A (en) 1988-09-28
HU896609D0 (en) 1990-02-28
DK153587D0 (da) 1987-03-26
DK153587A (da) 1987-09-28
IE62456B1 (en) 1995-02-08
DE3789330D1 (de) 1994-04-21
PH27210A (en) 1993-05-04
NO178546C (no) 1996-04-17
EP0243645A2 (fr) 1987-11-04
HU203117B (en) 1991-05-28
EG18175A (en) 1994-07-30
FI91876C (fi) 1994-08-25
ZA872230B (en) 1987-09-21
CS276385B6 (en) 1992-05-13
CS651989A3 (en) 1992-05-13
CN87102304A (zh) 1987-12-30
DD280765A5 (de) 1990-07-18
DK172221B1 (da) 1998-01-12
AU7064987A (en) 1987-10-01
NZ219764A (en) 1990-11-27
CS276179B6 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
MC2272A1 (fr) Utilisation de la substance active nommee flupirtine pour combattre des contractures musculaires
HUT68391A (en) Heterocyclic compounds substituted with side chain containing thio and carbonyl-amino-groups, pharmaceutical preparations containing said compounds as dual action inhibitors and process for preparing them
MA20919A1 (fr) Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
DE3571550D1 (en) Pharmaceutical preparation containing a combination of nitrendipin and enalapril and process for its preparation
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
EP0219782A3 (en) Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
CA1268468C (fr) Analogues des prostaglandines avec groupement thiabicycloheptane substitue
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ZA866810B (en) A pharmaceutical composition for the treatment of high blood pressure
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
DE68907163D1 (de) Antiepileptisch wirkende pyrazolopyridine.
DE3687448D1 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.
ES2000960A6 (es) Un procedimiento para preparar n(1-ciclohexenilmetil-2-pirrolidinilmetil)-8-etilsulfonil-1,5-benzodioxepan-6-carboxamida
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.